Brief: Elevation Oncology - On Sept 19, Co Received Notice From Nasdaq That Co No Longer Complies With Minimum Bid Price Requirement For Continued Listing
22/09/2023 22:55
Elevation Oncology Inc ELEV.O :
* ELEVATION ONCOLOGY - ON SEPT 19, CO RECEIVED NOTICE FROM
NASDAQ
THAT CO NO LONGER COMPLIES WITH MINIMUM BID PRICE REQUIREMENT
FOR CONTINUED LISTING
Source text for Eikon: ID:
Further company coverage: ELEV.O
Recent news on Elevation Oncology
See all newsBrief: Elevation Oncology Terminates License Agreement With CSPC Megalith Biopharmaceutical
U.S. RESEARCH ROUNDUP- Crane, Ryder System, Terex
Brief: Elevation Oncology Says Concentra To Buy Elevation Oncology For $0.36 Per Share Plus CVR
Elevation Oncology Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Elevation Oncology Inc - To Prepay Term Loan Under Loan & Security Agreement Dated July 27, 2022 - SEC Filing